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ABSTRACT 23 
A simple method to cryogenically preserve hepatocyte monolayers is currently not available but 24 
such a technique would facilitate numerous applications in the field of biomedical engineering, 25 
cell line development, and drug screening. We investigated the effect of trehalose and dimethyl 26 
sulfoxide (Me2SO) in cryopreservation of human hepatocellular carcinoma (HepG2) cells in 27 
suspension and monolayer formats. HepG2 cell monolayers were incubated for 24 h at varying 28 
concentrations of trehalose (50-150 mM) prior to cryopreservation to identify the optimum 29 
concentration for such preincubation. When trehalose alone was used as the cryoprotective agent 30 
(CPA), cells in monolayer format did not survive freezing while cells in suspension 31 
demonstrated 14% viability 24 h after thawing. Only 6-13% of cells in monolayers survived 32 
freezing in cell culture medium supplemented with 10% Me2SO, but 42% of cells were 33 
recovered successfully if monolayers were preincubated with 100 mM trehalose prior to freezing 34 
in the Me2SO supplemented medium. Interestingly, for cells frozen in suspension in presence of 35 
10% Me2SO, metabolic activity immediately following thawing did not change appreciably 36 
compared to unfrozen control cells. Finally, Raman spectroscopy techniques were employed to 37 
evaluate ice crystallization in the presence and absence of trehalose in freezing solutions without 38 
cells because crystallization may alter the extent of injury observed in cell monolayers. We 39 
speculate that biomimetic approaches of using protective sugars to preserve cells in monolayer 40 
format will facilitate the development of techniques for long-term preservation of human tissues 41 
and organs in the future. 42 
  43 
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INTRODUCTION 44 
The ability to effectively cryopreserve monolayers of hepatocytes on microtiter plates 45 
(MTPs) would facilitate cell based applications in drug discovery, cell line development, and 46 
bioartificial liver-support systems [2, 50, 52]. Despite several studies on cryopreservation of 47 
hepatocyte monolayers [36, 38, 50, 54] currently established cryopreservation protocols 48 
involving the use of 10% dimethyl sulfoxide (Me2SO) often yield poor outcomes, and simple 49 
methods that maintain high amounts of viable cells after freezing and thawing of monolayers for 50 
cell-banking and bioengineering purposes are still underdeveloped. While cryogenic storage of 51 
suspended cells is routinely performed in laboratories around the world [34, 47], some cell types 52 
(e.g., stem cells) are extremely difficult to cryopreserve in suspension [4]. Furthermore, it is 53 
highly desirable to preserve characteristics of adherent cells, for example, as in the case for 54 
networks of neurons [31]. In comparison to cryopreservation of suspended cells, protocols for 55 
cryopreservation of adherent cell monolayers are significantly underdeveloped. While 56 
researchers have recently started to systematically analyze the cryoprotective agent (CPA) 57 
requirements for adherent cells [27], there are two principal approaches to cryopreservation of 58 
cell monolayers that are independent of the CPA. One approach involves growing cells on small 59 
glass slides that are coated with an extracellular matrix (e.g. collagen). The slides are then 60 
removed from the cell-culture dish and exposed to a CPA solution in cryogenic vials which are 61 
cooled at a controlled rate to the desired temperatures [22, 49]. The second approach involves 62 
using passive cooling devices to cryopreserve cells directly in the culture dishes on which they 63 
grown (e.g. MTPs) after exposing the monolayers to a CPA [36, 38, 54]. While both protocols 64 
result in varying degrees of success in preserving cells in monolayers, protocols to preserve 65 
hepatocyte monolayers on MTPs are still underdeveloped.  66 
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CPAs play an important role in determining the outcome of the cryopreservation 67 
protocol. Along with traditional CPAs such as Me2SO, ethylene glycol, and glycerol, non-68 
reducing sugars such as trehalose and sucrose have been used to improve cryopreservation [6, 69 
24, 26, 37]. Concerns about the toxicity of Me2SO at room temperature warrant the development 70 
of alternative CPAs that provide a lower toxicity to the cell [25]. Another commonly used CPA, 71 
glycerol, displays lower toxicity to cells than Me2SO, but unfortunately often requires more 72 
cumbersome multi-step loading protocols [33, 37]. Use of trehalose (α-D-glucopyranosyl-α-D-73 
glucopyranoside) as a CPA has been explored due to its involvement in ameliorating 74 
physiological stresses in several organisms in nature. Trehalose is involved in stress and cold-75 
tolerance of several animals such as cysts of the brine shrimp Artemia franciscana, adults of the 76 
arctic springtail Megaphorura arctica, and the nematode Aphelenchus avenae [13, 17, 32]. 77 
Unfortunately, in absence of a specific sugar transporter, trehalose is impermeable to the plasma 78 
membrane and only small amounts of the sugar are taken up by cells via endocytosis after 79 
extended incubation periods with the sugar [23, 43]. Nevertheless, the addition of trehalose to 80 
Me2SO based freezing solution was found to increase the viability of human embryonic stem 81 
cells and primary hepatocytes in suspension which are known to be challenging to cryopreserve 82 
[28, 57], and viable endothelial cells have been obtained after cryopreservation when cells were 83 
cultured for 24 h with 0.2 M trehalose prior to freezing [8]. 84 
 We demonstrate in this study that at a freezing rate of 1 ºC • min-1 the commonly used 85 
cryoprotective compound Me2SO can be used to promote viability and maintain attachment of 86 
HepG2 cell monolayers after freezing and thawing. Our results also show that cryogenic 87 
outcomes for these HepG2 monolayers are improved by 24 h of incubation with the non-88 
reducing sugar trehalose prior to freezing in Me2SO-supplemented medium.   89 
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MATERIAL AND METHODS 90 
Chemicals. All chemicals for respiration measurements were purchased from Sigma-Aldrich (St. 91 
Louis, MO) or Fisher Scientific (Fair Lawn, NJ). Low endotoxin α,α-trehalose dihydrate was 92 
obtained from Pfanstiehl Inc. (Waukegan, IL). Water for solution preparation was purified with a 93 
Milli-Q Reagent Water System (Billerica, MA) to an electrical resistance of 18 mΩ.  94 
Cell Culture. Human hepatocellular carcinoma cells (HepG2) were obtained from the American 95 
Type Culture Collection (Manassas, VA) and grown in 75 cm
2
 cell culture flasks (Corning 96 
Incorporated, Corning, NY). Standard cell culture medium was composed of Opti-MEM I 97 
reduced serum medium (Invitrogen, Carlsbad, CA) supplemented with 5.5% fetal bovine serum 98 
(FBS) purchased from Atlanta Biologicals Inc. (Flowery Branch, GA), 100 units/ml penicillin, 99 
100 μg/ml streptomycin, and 250 ng/ml amphotericin B (MP Biomedicals, Santa Anna, CA). 100 
HepG2 cells were maintained in a humidified atmosphere of 6.5% CO2 and 93.5% air at 37 °C 101 
and the culture medium was renewed every 3 - 4 days. The cells were subcultured every seven 102 
days or before reaching 90% confluency. To subculture cells were dissociated using 0.25% 103 
trypsin plus 1 mM EDTA in balanced salt solution (Invitrogen, Carlsbad, CA) and reseeded at 104 
1.5 • 106 cells per 75 cm2 cell culture flasks. 105 
Impact of trehalose on cell proliferation. To assess the effect of trehalose on cell viability and 106 
proliferation, cells were seeded at a density of 1 • 106 cells per 60 mm culture dish (Corning 107 
Incorporated, Corning, NY) and the medium was exchanged after 24 h against medium 108 
containing trehalose concentrations ranging from 0-150 mM. Cells were then exposed to 109 
trehalose for 24 h followed by dissociation using 0.25% trypsin plus 1 mM EDTA in balanced 110 
salt solution, and the number of viable cells was determined by counting with a hemocytometer 111 
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(Hauser and Son, Philadelphia, PN) after 1:1 dilution of the sample with 0.4% trypan blue 112 
solution (Sigma-Aldrich, St. Louis, MO). In experiments to investigate sustained impacts of 113 
trehalose exposure on cell proliferation, cells that were exposed to trehalose for 24 h were sub-114 
cultured at 1 • 106 cells per 60 mm culture dish in trehalose free standard culture medium for an 115 
additional 24 h. The percentage of plated cells was calculated by dividing the number of cells 116 
with intact cell membranes in the control and treatment groups by the number of cells initially 117 
plated multiplied by 100.  118 
Cryopreservation of HepG2 cells in suspension. For cryopreservation experiments with cells that 119 
were exposed to trehalose concentrations ranging from 0-150 mM for 24 h the cells were 120 
detached using 0.25% trypsin plus 1 mM EDTA in balanced salt solution (Invitrogen, Carlsbad, 121 
CA, USA) and suspended in a freezing solution made as follows: 1 M trehalose was first 122 
prepared in cell culture grade water (Invitrogen, Carlsbad, CA) and the stock solution was 123 
filtered through a 0.22 µm sterile filter. This trehalose solution was added to Opti-MEM I 124 
supplemented with 20% FBS to yield a final concentration of 100 mM trehalose. Cells 125 
suspended in this solution were transferred into cryogenic vials (Thermo Fisher Scientific Inc., 126 
Waltham, MA) at a concentration of 1 • 106 cells • mL-1 and were transferred to -80 ºC inside an 127 
isopropanol-based passive freezing device  designed to achieve a rate of cooling close to -1°C • 128 
min
-1 
(Thermo Scientific Inc., Waltham, MA). After cooling to -80 ºC for 24 h cell samples were 129 
rapidly thawed at 37 ºC and 500 µL of this sample was transferred to a 60 mm culture dish 130 
containing 4.5 mL of standard culture medium. Thawed cells were cultured for 24 h and then 131 
counted after being detached as described above. The percentage of recovered cells was 132 
calculated by dividing the number of cells with intact cell membranes in the control (no 133 
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preincubation with trehalose) and treatment groups by the number of cells before freezing 134 
multiplied by 100.   135 
Cryopreservation of HepG2 cell monolayers. Cells to be frozen in the monolayer format were 136 
seeded at 0.25 • 106 cells per well in 500 μL of cell culture medium in 24-well plates (Corning 137 
Incorporated, Corning, NY) coated with collagen. To promote attachment of cells after thawing, 138 
collagen I from rat tail (Invitrogen, Carlsbad, CA) was diluted to 50 μg/ml in 20 mM acetic acid 139 
(Fischer Scientific, Fair Lawn, NJ) and added to each well of the cell culture plate at 5 μg 140 
collagen • cm-2.  Plates were incubated with the dissolved collagen for 1 h and after this 141 
incubation period the collage solution was removed and the plates were rinsed three times with 142 
200 μL Dulbecco’s phosphate buffered saline (Thermo Fisher Scientific Inc., Waltham, MA) to 143 
remove any residual acetic acid solution. The collagen treated plates were allowed to dry for one 144 
hour in a laminar flow hood and stored for less than one week at 4 °C prior to use. Before 145 
experimental treatments cells were allowed to attach for at least 1 h to the collagen coated plates 146 
in a humidified atmosphere of 6.5% CO2 and 93.5% air at 37 °C. After the cells adhered firmly 147 
to the culture plates in some experiments the medium was exchanged against medium that was 148 
supplemented with trehalose. Control cells received no trehalose and experimental cells were 149 
incubated with concentrations ranging from 50 to 200 mM trehalose for 24 h. Following the 150 
incubation period the culture medium was removed and cells were exposed for five minutes to 151 
different formulations of solutions supplemented with CPAs as listed in Table 1. After 5 min the 152 
solutions were removed and the plates placed inside a cell freezing container (BioCision, LLC, 153 
Larkspur, CA) and transferred to -80 ºC freezer. The freezing container includes a highly 154 
thermo-conductive stage (CoolCell® MP plate) placed in direct contact with the underside of the 155 
MTP that minimizes the temperature differential between wells and ensures a uniform rate of 156 
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thermal energy transfer of 1 ºC • min-1 during the freezing process. After 24 h at -80 ºC cells 157 
were rapidly thawed by addition of cell culture medium that was warmed to 37 °C.  158 
Metabolic activity and cell membrane integrity after thawing of HepG2 cell monolayers. In 159 
contrast to monolayer samples that were cultured for 24 h after thawing, the number of cells with 160 
intact membranes could not be determined by trypan blue exclusion immediately after freezing 161 
and thawing of the monolayers. HepG2 cells formed aggregates during trypsinization and 162 
reproducible cell numbers could not be enumerated. However, this problem was not observed if 163 
cells were cultured under standard conditions for 24 h after thawing. Metabolic activity of cells 164 
stored at -80 ºC for 24 h was monitored immediately after thawing with alamarBlue™ 165 
(BioSource International, Inc., Camarillo, CA). A working solution of alamarBlue™ was 166 
prepared by diluting the commercial stock solution 10-fold with standard cell culture medium. 167 
Then 0.5 ml of this working solution was added to each well of the 24-well culture plate. A 168 
sample of 0.1 ml was removed 2 h after addition of the working solution and transferred to a 96-169 
well plate (Fischer Scientific, Pittsburg, PA). The absorbance at λ = 570 nm and λ =  600 nm was 170 
measured with an absorbance microplate reader (Epoch 1, BioTek, Winooski, VT) and the 171 
percent of reduced alamarBlue™ (RA%) was calculated as: RA% = (((O2 • A1) – (O1 • 172 
A2))/((R1 • N2) – (R2 • N1))) • 100, where O1 (80586) is the molar extinction coefficient of 173 
oxidized alamarBlue at 570 nm and O2 (117216) is the molar extinction coefficient of oxidized 174 
alamarBlue at 600 nm. The values for R1 (155677) and R2 (14652) represent the molar 175 
extinction coefficients of reduced alamarBlue at 570 nm and 600 nm and A1 and A2 are the 176 
absorbance of test wells measured at 570 nm and 600 nm, respectively. N1 and N2 correspond to 177 
the absorbance values measured for negative control wells at 570 nm and 600 nm, respectively. 178 
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The membrane integrity of adherent cells immediately after freezing and thawing was 179 
determined using a SYTO 13 and propidium iodine membrane-integrity assay which can be 180 
performed on attached cells (Molecular Probes, Eugene, OR). The stock solution was prepared 181 
by adding 10 µL of a 1 mg • mL-1 SYTO 13 solution (aq.) and 5 µL of a 1.0 mg • mL-1 182 
propidium iodine solution (aq.) to 10 mL of DMEM (Invitrogen Corporation, Carlsbad, CA). An 183 
aliquot of 130 µL of this solution was then added to the attached cells and imaged using an 184 
inverted Zeiss microscope (Göttingen, Germany) equipped with dual fluorescence filter set 185 
(51004-V2, Chroma Technology, Brattleboro, VT). Images were processed using Image J 186 
processing software (National Institutes of Health, Bethesda, MD, USA). The percentage of cells 187 
with intact membranes (membrane integrity) was determined by counting live (green) and dead 188 
(red) cells on four representative images from the same sample.  189 
Respirometry on HepG2 cells. Oxygen consumption of control HepG2 cells grown for a 190 
minimum of ten passages after cryopreservation and of cells directly after thawing was measured 191 
at 37 ºC in 2 mL of MiR05 (110 mM sucrose, 60 mM potassium lactobionate, 20 mM taurine, 10 192 
mM KH2PO4, 3 mM MgCl2, 0.5 mM EGTA, 0.1% BSA, 20 mM HEPES-KOH, pH 7.1) at a 193 
concentration of 1 • 106 cells • mL-1. Cells suspended in 10% Me2SO + 5.5% FBS in Opti-MEM 194 
I were frozen to -80 ºC, stored for 24 h, and rapidly thawed as described above. The freezing 195 
solution was removed after thawing by centrifugation of cells at 175 g for 5 min, and the cell 196 
pellet was suspended in standard culture medium and kept on ice until processed for 197 
respirometry. Oxygen flux of control cells was determined before freezing and without exposure 198 
to the Me2SO contained in the freezing solution. In order to supply mitochondrial substrates 199 
cells from both samples were permeabilized by addition of digitonin dissolved in Me2SO at 10 200 
mg • mL-1 (final concentration 10 µg • 10-6 cells). This digitonin concentration was found to be 201 
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sufficient to permeabilize the plasma membrane of HepG2 cells with low impact on the integrity 202 
of the outer mitochondrial membrane. Proton leak respiration was initiated by adding 2 mM 203 
malate, 10 mM glutamate and 5 mM pyruvate, which supplies electrons to the electron transport 204 
system (ETS) via production of NADH by mitochondrial dehydrogenases. To induce oxidative 205 
phosphorylation (OXPHOS) 1 mM ADP was added and convergent electron entry to the 206 
ubiquinone pool via NADH and FADH2 was initiated by addition of 10 mM succinate. Potential 207 
damage to the outer mitochondrial membrane was investigated through addition of cytochrome c 208 
(10 µM). Leak respiration in presence of ADP and ATP was measured after addition of 209 
oligomycin (2 µg • mL)-1, and contribution of complex I to leak respiration was recorded after 210 
addition of rotenone (0.5 µM). Non-mitochondrial oxygen consumption was recorded after 211 
addition of 2.5 µM of antimycin A. Oxygen consumption was measured with an Oxygraph-2K 212 
(OROBOROS Instruments, Innsbruck, Austria) and DATLAB software (OROBOROS 213 
Instruments) was used for data analysis and acquisition. Oxygen flux (Jo2; pmol O2 • s
-1
 • 10-6 214 
cells) was calculated as the time derivative of oxygen concentration.  215 
Raman Microspectroscopy. Micro-Raman spectroscopy allows the probing of a small volume by 216 
combining a confocal microscope with the spectroscopy system. We have used micro-Raman 217 
spectroscopy in this study and refer to the spectra obtained as “Raman spectra”. Raman spectra 218 
were made with a WITec Alpha300 system (wavelength of incident laser light, λ = 532 nm) and 219 
a 10 x objective (WITec Instruments Corp, Knoxville, Tennessee). The incident laser power was 220 
carefully tuned to avoid sample damage or laser induced heating and measurements were thus 221 
performed at around 25 mW incident laser power. A Linkam cryogenic stage (FDCS 196, 222 
Linkam Scientific Instruments, Surrey, UK) was used to cool the CPA solutions at controlled 223 
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freezing rates. Raman spectra were obtained at definite intervals during freezing and thawing of 224 
the solutions.  225 
Statistical analyses. Data were analyzed with a one-way analysis of variance (ANOVA) on ranks 226 
followed by comparison of experimental groups with the appropriate control group (Holm-Sidak 227 
method) or 2-way ANOVA followed by comparison of experimental groups with the appropriate 228 
control groups (Holm-Sidak method). SigmaPlot 12.5 (Systat Software Inc., San Jose, CA) was 229 
used for the analyses.  230 
  231 
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RESULTS  232 
Effect of trehalose on HepG2 cell proliferation and viability. In order to evaluate the protective 233 
potential of trehalose in cryopreservation of HepG2 cells the impact of this sugar on cell viability 234 
and proliferation was investigated since increased extracellular osmolyte concentrations 235 
inevitably cause osmotic stress to cells. Compared to untreated controls the numbers of viable 236 
cells were decreased after 24 h of exposure to the sugar at all concentrations investigated (p < 237 
0.05, n = 9 experiments). Strikingly, no net increase in cell numbers occurred over 48 h at 150 238 
mM trehalose, the highest concentration investigated, and only 1.06 ± 0.03 (SE) • 106 viable cells 239 
were recovered from 1 • 106 cells plated (Fig. 1A). In addition to the acute effect of trehalose on 240 
cell proliferation (a hyperosmotic challenge) prolonged effects that persisted after the sugar was 241 
removed (a hypoosmotic challenge) were also observed. Cell numbers in control samples 242 
increased to 144 ± 4.2 (SE) % of the original value during 24 h after plating, but in samples that 243 
were exposed to concentrations of 100 mM and 150 mM trehalose, prior to seeding, only about 244 
83% of cells were recovered (Fig. 1B, n = 9) showing that osmotic challenges in either direction 245 
(hypoosmotic or hyperosmotic) causes reductions in cell viability.  246 
Cryopreservation of HepG2 cells in suspension and monolayer formats. We tested whether 247 
trehalose provides cellular protection during one freeze thaw cycle to -80 ºC when present as the 248 
only cryoprotective agent (CPA). We tested the cryoprotective effects of sugar incubation at 249 
concentrations ranging from 0 to 150 mM. The experimental cells (with trehalose) and control 250 
cells (without trehalose) were frozen to -80 ºC suspended in a solution composed of cell culture 251 
medium supplemented with 20 % FBS and 100 mM trehalose. Under these conditions incubation 252 
with 100 mM trehalose prior to freezing provided the highest protection to the plasma membrane  253 
(p < 0.05, n = 9) compared to controls, and 13.8 ± 0.26 (SE) % of cells were recovered 24 h after 254 
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thawing and plating of samples frozen in suspension (Fig. 2). Unfortunately, cell monolayers did 255 
not survive freezing in this solution (Table 1), and cell viability was not increased after 256 
incubation with 100 mM trehalose (data not shown). Three additional freezing solutions were 257 
investigated next and HepG2 monolayers were frozen in these solutions with a trehalose 258 
preincubation step. Under theses condition 10 % Me2SO provided the same protection in either 259 
90 % FBS or in cell culture medium (Table 1). Due to the fact that FBS is rather expensive we 260 
utilized culture medium supplemented with 10 % Me2SO and 5.5 % FBS in the subsequent 261 
experiments.  262 
Cryopreservation of HepG2 monolayers after incubation with trehalose. Me2SO is widely used 263 
in cryopreservation of cells in suspension but protection of confluent HepG2 cell monolayers 264 
was poor. Only 10.5 ± 1.8 (SE) % of control cells before freezing were recovered after thawing 265 
and 24 h recovery without trehalose preincubation prior to freezing (Table 1). To investigate if 266 
preincubation with trehalose improves viability of HepG2 cell monolayers frozen in presence of 267 
Me2SO, alamarBlue assays were performed. In presence or absence of trehalose in the Me2SO 268 
based freezing solution, alamarBlue reduction rates immediately after thawing of HepG2 269 
monolayers were statistically unchanged after incubation with trehalose concentrations ranging 270 
from 50 to 150 mM as compared to controls without trehalose incubation (Fig. 3). Surprisingly, 271 
robust alamarBlue reduction rates were observed after thawing of control samples (without 272 
trehalose incubation), which yielded low percentages of recovered cells if cultured for 24 h after 273 
thawing (Table 1). Since the active compound, resazurin, in alamarBlue is reduced by cellular 274 
dehydrogenases [41] we speculated that most enzymes might be well protected during freezing 275 
in presence of 10 % Me2SO and resazurin reduction rates measured immediately after thawing 276 
are not indicative of cell viability after cryopreservation of cell monolayers. However, cells 277 
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could not be completely detached from the collagen matrix directly after thawing (see Materials 278 
and Methods). Therefore, trypan blue exclusion assays were performed on the cells 24 h after 279 
thawing and culture under standard conditions.  280 
Cell counts revealed that preincubation with trehalose concentrations ranging from 50 to 200 281 
mM significantly improved recovery of cells frozen as monolayers compared to controls without 282 
exposure to trehalose (n = 7-12, p < 0.05) (Fig. 4A). Furthermore, preincubation with 100 mM 283 
trehalose significantly outperformed all other concentrations evaluated (Fig. 4A). To investigate 284 
if addition of trehalose to the freezing solution further improves cryopreservation outcome, the 285 
same series of experiments was repeated in presence of 100 mM extracellular trehalose in the 286 
freezing solution along with 10% Me2SO (Fig. 4B). Two-way analysis of variance (ANOVA) 287 
detected a significant interaction between trehalose preincubation and the presence or absence of 288 
trehalose in the freezing buffer (p = 0.003) and surprisingly, the addition of the sugar to cell 289 
culture medium containing 10 % Me2SO caused a 50% reduction in cell recovery (Fig. 4B). 290 
These results were confirmed by live-dead staining performed immediately after thawing (Fig. 291 
5). We  observed a lower percentage of cells staining positive for ethidium homodimer (dead cell 292 
staining) when HepG2 monolayers were preincubated with 100 mM trehalose and frozen in cell 293 
culture medium supplemented with only 10 % Me2SO (Fig. 5A.3), compared to a freezing 294 
solution supplemented with 10 % Me2SO and 100 mM trehalose (Fig. 5B.3). The percentage of 295 
cells with intact membranes decreased from about 80% to about 60% after the addition of 296 
trehalose to the freezing solution (Table 2, p < 0.001). However, similar to our alamarBlue data 297 
obtained directly after thawing of HepG2 monolayers, no significant differences among the 298 
preincubation groups were detected in the stained HepG2 monolayers (n = 4; p = 0.93, Table 2).  299 
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Respiration of HepG2 cells cryopreserved in suspension format. Based on our 300 
alamarBlue data we speculated that cellular dehydrogenases may be preserved during 301 
cryopreservation in presence of Me2SO and remain functional directly after thawing. 302 
Unfortunately, respiration measurements of cells frozen in the monolayer format were not 303 
possible since cells could not be separated from the collagen matrix directly after thawing (see 304 
Materials and Methods), and we decided to investigate the impact of freezing on cells in 305 
suspension on the activities of mitochondrial dehydrogenases and bioenergetically properties. 306 
After the addition of malate plus glutamate and pyruvate to never-frozen, permeabilized HepG2 307 
cells (supplying NADH to complex I) the oxygen flux was 8.1 ± 0.5 (SE) pmol O2 • sec 
-1
 • 10-6 308 
cells (n = 4). This value was indistinguishable from cells that were frozen in suspension format 309 
to -80 ºC in cell culture medium supplemented with 10 % Me2SO and assessed directly after 310 
thawing (Fig. 6). Both never-frozen control and cryopreserved cells showed an about 3.5-fold 311 
increase in oxygen flux after engaging the phosphorylation system by addition of 1 mM ADP 312 
and a further increase of about 80% was recorded after addition of succinate which supplies 313 
electrons to the mitochondrial ubiquinone pool via the bound flavin adenine dinucleotide (FAD) 314 
of the succinate dehydrogenase complex. Importantly, the response to cyt c addition was 315 
indistinguishable between control cells and cryopreserved cells, indicating a well preserved outer 316 
mitochondrial membrane immediately after cryopreservation. In summary, directly after thawing 317 
all investigated bioenergetics functions of mitochondria were unchanged from control cells (Fig. 318 
6). While we aimed to use alamarBlue and respiration assays as tools to quantify changes in 319 
cellular properties immediately after thawing no changes in cellular physiology for HepG2 cells 320 
could be detected with these two assays. In presence of 10% Me2SO cryopreservation outcomes 321 
apparently depend on events that are difficult to detect directly after thawing and the impact of 322 
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trehalose on preservation of HepG2 monolayers could only be demonstrated after 24 h of 323 
recovery by trypan blue exclusion assays (see above).  324 
Decrease in ice crystal formation in the presence of trehalose. The behavior of water at low 325 
temperatures and the formation of ice crystals have profound effects on cryopreservation [5]. We 326 
speculated that the addition of trehalose to the Me2SO based freezing buffer may change the ice-327 
formation characteristics of water, and Raman microspectroscopy is an excellent tool to 328 
characterize these changes from a molecular standpoint. Ice formation can be easily detected by 329 
observing Raman spectra of water at low temperatures [20]. The phenomenon of ice formation 330 
affects the O-H stretching modes of water (2900–3600 cm−1 range), which indicates the state of 331 
intramolecular O-H pairs and hydrogen bonds. Based on the nature of hydrogen bonds, the O-H 332 
stretch region of the water spectrum consists of two principal regions known as symmetric and 333 
asymmetric stretches, with Gaussian shaped peaks around 3242 cm
-1
 and 3451 cm
-1
, respectively 334 
[5]. The symmetric peak has been attributed to the O-H vibration in tetra-bounded water 335 
molecules that are under influence of fully developed hydrogen bonds, while the asymmetric 336 
peak correspond to the O-H vibrations of water molecules that have partially or incompletely 337 
developed bonds (hence free water) [9]. In order to understand the impact of trehalose on ice 338 
formation in our freezing buffer Raman microspectroscopy was performed without cells present. 339 
Onset of ice nucleation during freezing was indicated in by the appearance of a definitive ice 340 
peak at 3100 cm
-1
 (Fig. 7). If 100 mM trehalose was added to the 10% Me2SO solution, we 341 
observed a significant decrease (>50%) in the intensity of the ice peak at -170 
0
C (Fig. 7). This 342 
signifies that presence of trehalose at cryogenic temperatures leads to a decrease in ice-crystal 343 
formation compared to Me2SO alone. Furthermore, the presence of trehalose affected the state of 344 
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the water molecules at cryogenic temperatures. A significant decrease of both the symmetric 345 
(3242 cm
-1
) and the asymmetric peaks (3451 cm
-1
) was observed in presence of trehalose.     346 
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Discussion 347 
Animals in the temperate and polar regions of the globe that survive cooling to subzero body 348 
temperatures [3, 12, 21, 51] experience reductions in cellular water content, due to the 349 
precipitation of water as ice, if the animal fails to maintain a super-cooled state. Extracellular ice 350 
formation will lead to osmotic dehydration of cells and tissues which might protect from 351 
intracellular ice formation (IIF) an event lethal for most animals. Some animals are known to 352 
accumulate compatible osmolytes [59], prior or during the onset of cellular water limitation and 353 
some exceptional species are capable of surviving the formation of intracellular ice [46, 48, 55]. 354 
Since cells in freeze-tolerant animals experience dehydration in highly organized tissues, we 355 
hypothesized that compatible osmolytes in general and protective sugars such as trehalose in 356 
particular are useful in cryopreservation of cell monolayers. We have demonstrated in this study 357 
that incubation of confluent HepG2 monolayers with 100 mM trehalose prior to freezing 358 
increases cell viability by roughly 400% after thawing and recovery.  359 
Trehalose is a non-reducing disaccharide with unique chemical properties that 360 
accumulates in some organisms that survive freezing and desiccation in nature [18, 42]. Similar 361 
to the proposed functions of trehalose in anhydrobiosis [16], the presence of the sugar during 362 
freezing might aid in the protection of membranes and proteins through multiple mechanisms. 363 
Three hypotheses have been postulated to account for the mechanisms by which trehalose 364 
preserves cellular structures during reductions in water activity: (1) the water replacement 365 
hypothesis, which suggests that sugars can replace water molecules by forming hydrogen bonds 366 
with polar residues and stabilize cellular structures to prevent denaturation, (2) the preferential 367 
exclusion theory which suggests that trehalose attracts water away from macromolecules, 368 
compacts the macromolecule and reduces the probability to denature, and (3) the vitrification 369 
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hypothesis suggests that the sugar solutions form amorphous glasses, which reduces structural 370 
fluctuations throughout freezing  [14, 15, 53, 58]. Glass formation (Tg) occurs when a liquid is 371 
cooled sufficiently quickly and the viscosity becomes so great that the rearrangement of 372 
molecules in the liquid becomes extremely slow or stops, which occurs at approximately -100 ºC 373 
for trehalose solutions with weight fractions of water > 0.75 [11, 56].  374 
To exert maximal protective properties trehalose has to be present on both sides of the 375 
plasma membrane [24], but unfortunately the sugar is only readily permeable to cells that 376 
express a specific transporter in their plasma membrane [10; 29]. One technique to accumulate 377 
some levels of intracellular trehalose in mammalian cells is through endocytosis after adding 378 
trehalose to the culture medium for extended periods of time [8, 23], and we hypothesized that 379 
low levels of trehalose also accumulate intracellular in HepG2 cells after 24 h of exposure to the 380 
sugar as demonstrated for J774.Q1 mouse macrophages [23]. In order to successfully load 381 
intracellular trehalose as a cryoprotectant in biomedical applications the optimal concentration 382 
used during pre-incubations has to be carefully optimized since the sugar can cause acute and 383 
prolonged reductions in cell viability and proliferation (Fig. 1). We found that intracellular 384 
loaded trehalose in presence of 100 mM extracellular trehalose conferred some protection to 385 
cells frozen in solution but no viable cells were recovered if cells were frozen as monolayers 386 
(Fig. 2, Tab. 1).  Constraints for cells frozen in solution are different from the physical stress 387 
cells experience when frozen as monolayers. Furthermore, the formation of intracellular ice may 388 
be less harmful to cells in monolayers than for isolated cells frozen in suspension has been 389 
demonstrated [1], and some suggest that IIF is preceded by damage to the plasma membrane and 390 
IIF is a result of cell injury not the cause [39]. 391 
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The increase in recovered viable cells observed after preincubation with trehalose may 392 
not be due only to the cryoprotective properties of the sugar, but also to an indirect effect of 393 
osmotic stress, as suggested by [44]. We do agree that osmotic stress prior to dehydration may 394 
activate survival pathways that might have protective effects when cells experience dehydration 395 
during freezing [7]. Nevertheless, based on extensive research that demonstrates the protective 396 
effects of trehalose on membranes and proteins during desiccation and freezing [18, 19] this 397 
‘preconditioning’ effect is in our opinion rather minor compared to the direct cell stabilizing 398 
effects of trehalose.  399 
The main factors that impact viability of cells after freezing and thawing, in both 400 
monolayer and suspension formats, is ice-crystal formation and hyperosmotic stress due to 401 
precipitation of water as ice [26, 34, 35]. Water that is below its freezing point is referred to as 402 
supercooled and has a higher chemical potential at a given subzero temperature than that of ice 403 
or water in a solution that is in equilibrium with ice [35]. As extracellular ice precipitates, a 404 
significant increase in the concentration of all other solutes occurs in the remaining liquid water 405 
fraction. This might lead to excessive dehydration that may result in irreversible membrane 406 
alteration and cell death. The formation of extracellular ice, therefore, results in an increased 407 
osmotic pressure in the extracellular space that creates an osmotic gradient across the plasma 408 
membrane, which provides a driving force for the efflux of water from the cell [39]. Intracellular 409 
ice formation (IIF) may occur during freezing rates that are substantially higher than 1 ºC • min-1 410 
but do not approach ultra-rapid freezing rates used in vitrification techniques [34, 35]. 411 
Extracellular and intracellular ice crystals that form during freezing and thawing may penetrate 412 
cellular membranes and will inevitably lead to a reduction in the amount of viable cells that are 413 
recovered after cryopreservation. A highly controlled rate of freezing is vital to ensure proper 414 
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movement of water across the plasma membrane which allows osmotic dehydration to reach 415 
equilibrium with intracellular and extracellular contents in order to prevent IIF [33, 47]. We 416 
found that at a freezing rate of 1 ºC • min-1 only about 10 % of cells frozen as monolayers could 417 
be recovered whereas recovery for cells in suspension at this freezing rate is commonly above 418 
90% (data not shown). Me2SO protects as penetrating CPA and protect cells during 419 
cryopreservation in part due to the ability to reduce the concentration of damaging solutes in the 420 
unfrozen water fraction during the freezing and thawing processes [35]. However, osmotic 421 
dehydration during freezing appears to be more detrimental for cells that are frozen as 422 
monolayers than in suspension. Cell monolayer are firmly attached to the extracellular matrix 423 
and before the eutectic temperature is reached less able to move into the remaining unfrozen 424 
water fraction compared with cells frozen in suspension [40]. The combination of intracellular 425 
trehalose and Me2SO might mitigate physical stresses and help to stabilize cellular membranes 426 
during freezing of cell monolayers as has been demonstrated for freezing of vesicles [45]. 427 
Surprisingly, we found that cellular respiration and resazurin reduction was unchanged 428 
immediately after thawing of cells frozen in suspension or in the monolayer format, respectively 429 
(Figs. 3, 4). Larsen [30] observed that freezing of skeletal muscle tissue in presence of Me2SO 430 
negatively impacts respiration fueled by complex I. These observations indicate that different 431 
cell and tissue types respond differently to cryopreservation but that some cellular samples might 432 
be stored at -80 ºC prior to assessment of bioenergetics properties. We are currently investigating 433 
the optimal conditions and concentrations of trehalose used in preincubation to store isolated 434 
mitochondria, cells, and tissues at cryogenic temperatures prior to high-resolution respirometry. 435 
A comprehensive study of mitochondrial properties is a time consuming process and 436 
cryopreservation of samples prior to high-resolution respirometry would greatly simplify the 437 
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experimental workflow and increase the accessibility to use this technology as a diagnostic tool 438 
in medicine.  439 
The Raman data sheds light on the effect of presence of trehalose in CPA at the 440 
molecular level. Ice formation in extracellular solution can be directly linked to cellular injury at 441 
cryogenic temperatures for both attached and suspended cells. Decreased intensity of the ice 442 
peak at cryogenic temperatures (Fig. 7) indicates a protective effect of trehalose. The 443 
simultaneous decrease of both the symmetric and asymmetric peaks of the water molecules in the 444 
spectra in presence of trehalose further indicates that presence of trehalose in CPA is capable of 445 
decreasing water activity and thus rendering a protective effect in cryopreservation. In contrast to 446 
this observation, we found the highest recovery of viable cells after preincubation with 100 mM 447 
trehalose but in absence of additional trehalose in the freezing buffer (Figs. 4, 5). This finding 448 
might be specific to hepatocytes since we did not observe a reduction in viability for 449 
neuroblastoma cells frozen in the presence of trehalose and Me2SO compared to Me2SO alone 450 
(Bailey, Nathan, Menze, unpublished observations). HepG2 cells might be especially sensitive to 451 
additional hyperosmotic stresses during freezing and thawing caused by the addition of non-452 
permeating compounds to the freezing buffer. Furthermore, during processing for 453 
cryopreservation the extracellular solution containing 100 mM was simply removed and the cells 454 
were loaded with Me2SO. The residual trehalose from the incubation medium might be 455 
sufficient to confer protection without causing additional hyperosmotic stress during freezing 456 
and thawing. In summary our study demonstrates that trehalose incubation facilitates 457 
preservation of cells in monolayer format. In order to develop trehalose based techniques for 458 
long-term preservation of human tissues and organs in the future more efficient loading protocols 459 
for the sugar are likely needed.  460 
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 469 
Table 1: Composition of solutions employed for freezing of hepatocellular carcinoma (HepG2) 470 
cell monolayers and cell recovery after freezing without trehalose pre-incubation. 471 
 472 
 
Composition of freezing solution 
 
% Live Cell Recovery
1 
 
20% FBS + 100 mM trehalose in Opti-MEM I 
 
0.00 ± 0.0 
 
10% Glycerol + 5.5% FBS in Opti-MEM I 
 
6.4 ± 0.9 
 
90% FBS + 10% Me2SO 
 
12.1 ± 2.5* 
 
10% Me2SO + 5.5% FBS in Opti-MEM I 
 
10.5 ± 1.8* 
 
 473 
1
Live cell recovery is expressed in % of cells that were recovered after thawing followed by 24 h 474 
of standard cell culture conditions compared to numbers of cells before freezing. Only cells that 475 
excluded trypan blue were used to calculate the fraction of viable cells (n = 8-30, ±SE). Asterisks 476 
indicate no significant differences in recovery between cells frozen in 10% Me2SO in FBS, or 477 
10% Me2SO in cell culture medium (p = 0.297).  478 
 479 
 480 
 481 
 482 
 483 
 484 
 485 
 486 
 487 
 488 
 489 
 490 
 491 
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Table 2: Membrane integrity of hepatocellular carcinoma cells (HepG2) measured immediately 492 
after thawing. Cell monolayers were incubated with different concentrations of trehalose for 24 h 493 
before freezing.  494 
 495 
Trehalose [mM]  
 
24 h preincubation 
Buffer 1 (no trehalose) 
 
% Membrane integrity
1
 
 
Buffer 2 (100 mM trehalose) 
 
% Membrane integrity
1
  
 
0 
 
80.6 ± 5.0 
 
68.3 ± 2.6 
 
50 
 
87.1 ± 3.6 
 
57.5 ± 3.8 
 
100 
 
90.2 ± 4.2 
 
47.8 ± 8.8 
 
150 
 
69.2 ± 8.4 
 
 
69.5 ± 6.2 
 496 
1
Membrane integrity is expressed in % of cells staining positive for SYTO 13 and negative for 497 
propidium iodine divided by the total number of cells. Monolayers were frozen in 10% Me2SO + 498 
5.5% FBS in Opti-MEM I (Buffer 1) or 10% Me2SO + 5.5% FBS in Opti-MEM I + 100 mM 499 
trehalose (Buffer 2). Data are based on enumerating cell numbers in random areas of thawed 500 
monolayers (n = 4 ±SE). Independent from the concentration of trehalose during preincubation 501 
the presence of trehalose in the freezing buffer significantly reduced the number of cells with 502 
intact membranes after thawing (p < 0.001). No significant differences in membrane integrity 503 
were found among the trehalose concentrations used in the 24 h pre-incubation step (p = 0.093).  504 
 505 
  506 
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Figure Legends 507 
Fig. 1: Impact of trehalose on cell proliferation. A) Effect at the end of 24 h of trehalose 508 
exposure. A reduction in proliferation of human hepatocellular carcinoma cells (HepG2) is 509 
observed in culture media supplemented with trehalose. B) Effect 24 h after the removal of 510 
trehalose. HepG2 cells transiently treated with trehalose showed prolonged inhibitions in cell 511 
proliferation after removal of the sugar. *Statistically significant different to 0 mM trehalose (n = 512 
9, ±SE). Significance level was set at p ≤ 0.05. 513 
Fig. 2: Percentage of cells recovered after freezing of suspended cells exposed to trehalose 514 
for 24 h. HepG2 cells were incubated with trehalose for 24 h and frozen to -80 ºC in culture 515 
medium supplemented with 100 mM trehalose and 20 % FBS. Incubation with 100 mM 516 
trehalose for 24 h confers highest amount of protection to suspended cells (n = 9, ±SE) measured 517 
after 24 h of cell recovery. *Statistically significant different to 0 mM trehalose. Significance 518 
level was set at p ≤ 0.05. 519 
Fig. 3: Cellular alamarBlue reduction immediately after thawing. HepG2 cells were 520 
incubated with trehalose for 24 h and frozen in cell culture medium supplemented with 10 % 521 
Me2SO (black bars) or with 10 % Me2SO plus 100 mM trehalose (gray bars). No statistically 522 
significant differences to the respective controls at 0 mM trehalose were detected immediately 523 
after thawing (n = 6-12, ±SE). Significance level was set at p ≤ 0.05. 524 
Fig. 4: Trehalose pre-incubation increases percentage of cells recovered after freezing of 525 
HepG2 monolayers. HepG2 cell monolayers were incubated for 24 h with different 526 
concentrations of trehalose and frozen in culture medium supplemented with A) 10 % Me2SO or 527 
B) 10 % Me2SO plus 100 mM trehalose. Cell samples were thawed by addition of culture 528 
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medium and cell counts were performed after a 24 h recovery period (n = 7-12, ±SE). 529 
*Statistically significant different to 0 mM trehalose. 
#
Statistically significant different to all 530 
other treatments tested. Significance level was set at p ≤ 0.05. 531 
Fig. 5: Membrane integrity of HepG2 cells frozen in monolayer format immediately after 532 
thawing. HepG2 control cells without trehalose incubation (A,B-1) and cells  incubated with 50 533 
mM (A,B-2), 100 mM (A,B,-3), or 150 mM (A,B-4) trehalose were frozen at a rate of 1 ºC per 534 
minute to -80 ºC, thawed, and stained for viable (green) and dead (red) cells. Monolayers were 535 
frozen in cell culture medium supplemented with 10 % Me2SO (panel A), or with 10 % Me2SO 536 
plus 100 mM trehalose (panel B).  537 
Fig. 6: High-resolution respirometry after freezing and thawing of suspended HepG2 cells 538 
in presence of 10 % Me2SO. Respiration of hepatocellular carcinoma cells (HepG2) was 539 
measure before (black bars) and after cells were frozen to -80 ºC in cell culture medium 540 
supplemented with 10 % Me2SO (gray bars). No significant differences in respiration rates were 541 
observed immediately after thawing compared to controls before freezing. Oxygen flux is shown 542 
after successive additions of cells (HepG2), digitonin (Dig), malate plus glutamate plus pyruvate 543 
(MGP), succinate (S), ADP (D), cytochrome c (Cyt-c), oligomycin (Omy), rotenone (Rot), and 544 
antimycin A (Ama) (n = 4, ±SE).  545 
Fig. 7: Raman microspectroscopy on CPA solutions at -170 ºC. The presence of trehalose 546 
leads to a significant reduction in ice-crystal formation as indicated by a reduced ice peak at 547 
3100 cm
-1
.   548 
28 
 
References: 549 
[1] J.P. Acker, and L.E. McGann, Protective effect of intracellular ice during freezing? 550 
Cryobiology 46 (2003) 197-202. 551 
[2] E. Alexandre, C. Viollon-Abadie, P. David, A. Gandillet, P. Coassolo, B. Heyd, G. Mantion, 552 
P. Wolf, P. Bachellier, D. Jaeck, and L. Richert, Cryopreservation of adult human 553 
hepatocytes obtained from resected liver biopsies. Cryobiology 44 (2002) 103-13. 554 
[3] F. Ali, and D.A. Wharton, Cold tolerance abilities of two entomopathogenic nematodes, 555 
Steinernema feltiae and Heterorhabditis bacteriophora. Cryobiology 66 (2013) 24-9. 556 
[4] A.F. Beier, J.C. Schulz, D. Dorr, A. Katsen-Globa, A. Sachinidis, J. Hescheler, and H. 557 
Zimmermann, Effective surface-based cryopreservation of human embryonic stem cells 558 
by vitrification. Cryobiology 63 (2011) 175-85. 559 
[5] C. Branca, S. Magazu, G. Maisano, and P. Migliardo, Anomalous cryoprotective 560 
effectiveness of trehalose: Raman scattering evidences. J Chem Phys 111 (1999) 281-561 
287. 562 
[6] K.G. Brockbank, L.H. Campbell, E.D. Greene, M.C. Brockbank, and J.G. Duman, Lessons 563 
from nature for preservation of mammalian cells, tissues, and organs. In Vitro Cell Dev 564 
Biol Anim 47 (2011) 210-7. 565 
[7] M.B. Burg, J.D. Ferraris, and N.I. Dmitrieva, Cellular response to hyperosmotic stresses. 566 
Physiol Rev 87 (2007) 1441-74. 567 
[8] L.H. Campbell, and K.G. Brockbank, Culturing with trehalose produces viable endothelial 568 
cells after cryopreservation. Cryobiology 64 (2012) 240-4. 569 
[9] D.M. Carey, and G.M. Korenowski, Measurement of the Raman spectrum of liquid water. J 570 
Chem Phys 108 (1998) 2669-75. 571 
29 
 
[10] N. Chakraborty, M.A. Menze, J. Malsam, A. Aksan, S.C. Hand, and M. Toner, 572 
Cryopreservation of spin-dried mammalian cells. PLoS One 6 (2011) e24916. 573 
[11] T. Chen, A. Fowler, and M. Toner, Literature review: supplemented phase diagram of the 574 
trehalose-water binary mixture. Cryobiology 40 (2000) 277-82. 575 
[12] M.S. Clark, and M.R. Worland, How insects survive the cold: molecular mechanisms-a 576 
review. J Comp Physiol B 178 (2008) 917-33. 577 
[13] M.S. Clark, M.A. Thorne, J. Purac, G. Burns, G. Hillyard, Z.D. Popovic, G. Grubor-Lajsic, 578 
and M.R. Worland, Surviving the cold: molecular analyses of insect cryoprotective 579 
dehydration in the Arctic springtail Megaphorura arctica (Tullberg). BMC Genomics 10 580 
(2009) 328. 581 
[14] J.S. Clegg, P. Seitz, W. Seitz, and C.F. Hazlewood, Cellular responses to extreme water 582 
loss: the water-replacement hypothesis. Cryobiology 19 (1982) 306-16. 583 
[15] J.H. Crowe, L.M. Crowe, and D. Chapman, Preservation of membranes in anhydrobiotic 584 
organisms: the role of trehalose. Science 223 (1984) 701-3. 585 
[16] J.H. Crowe, F.A. Hoekstra, and L.M. Crowe, Anhydrobiosis. Annu Rev Physiol 54 (1992) 586 
579-99. 587 
[17] J.H. Crowe, J.F. Carpenter, and L.M. Crowe, The role of vitrification in anhydrobiosis. 588 
Annu Rev Physiol 60 (1998) 73-103. 589 
[18] J.H. Crowe, Trehalose as a "chemical chaperone": fact and fantasy. Adv Exp Med Biol 594 590 
(2007) 143-58. 591 
[19] L.M. Crowe, J.H. Crowe, A. Rudolph, C. Womersley, and L. Appel, Preservation of freeze-592 
dried liposomes by trehalose. Arch Biochem Biophys 242 (1985) 240-7. 593 
30 
 
[20] J. Dong, J. Malsam, J.C. Bischof, A. Hubel, and A. Aksan, Spatial distribution of the state 594 
of water in frozen mammalian cells. Biophys J 99 (2010) 2453-9. 595 
[21] D. Doucet, V.K. Walker, and W. Qin, The bugs that came in from the cold: molecular 596 
adaptations to low temperatures in insects. Cell Mol Life Sci 66 (2009) 1404-18. 597 
[22] S.L. Ebertz, and L.E. McGann, Cryoinjury in endothelial cell monolayers. Cryobiology 49 598 
(2004) 37-44. 599 
[23] G.D. Elliott, X.H. Liu, J.L. Cusick, M. Menze, J. Vincent, T. Witt, S. Hand, and M. Toner, 600 
Trehalose uptake through P2X7 purinergic channels provides dehydration protection. 601 
Cryobiology 52 (2006) 114-27. 602 
[24] A. Eroglu, M.J. Russo, R. Bieganski, A. Fowler, S. Cheley, H. Bayley, and M. Toner, 603 
Intracellular trehalose improves the survival of cryopreserved mammalian cells. Nat 604 
Biotechnol 18 (2000) 163-7. 605 
[25] G.M. Fahy, Cryoprotectant toxicity neutralization. Cryobiology 60 (2010) S45-53. 606 
[26] A. Fowler, and M. Toner, Cryo-injury and biopreservation. Ann N Y Acad Sci 1066 (2005) 607 
119-35. 608 
[27] A. Fry, and A. Higgins, Measurement of Cryoprotectant Permeability in Adherent 609 
Endothelial Cells and Applications to Cryopreservation. Cell Mol Bioengin 5 (2012) 287-610 
298. 611 
[28] E. Katenz, F.W. Vondran, R. Schwartlander, G. Pless, X. Gong, X. Cheng, P. Neuhaus, and 612 
I.M. Sauer, Cryopreservation of primary human hepatocytes: the benefit of trehalose as 613 
an additional cryoprotective agent. Liver Transpl 13 (2007) 38-45. 614 
[29] T. Kikawada, A. Saito, Y. Kanamori, Y. Nakahara, K. Iwata, D. Tanaka, M. Watanabe, and 615 
T. Okuda, Trehalose transporter 1, a facilitated and high-capacity trehalose transporter, 616 
31 
 
allows exogenous trehalose uptake into cells. Proc Natl Acad Sci U S A 104 (2007) 617 
11585-90. 618 
[30] S. Larsen, C. Wright-Paradis, E. Gnaiger, J.W. Helge, and R. Boushel, Cryopreservation of 619 
human skeletal muscle impairs mitochondrial function. Cryo Letters 33 (2012) 170-6. 620 
[31] W. Ma, T. O'Shaughnessy, and E. Chang, Cryopreservation of adherent neuronal networks. 621 
Neurosci Lett 403 (2006) 84-9. 622 
[32] K.A.C. Madin, and J.H. Crowe, Anhydrobiosis in nematodes: Carbohydrate and lipid 623 
metabolism during dehydration. J Exp Zool 193 (1975) 335-42. 624 
[33] P. Mazur, R.H. Miller, and S.P. Leibo, Survival of frozen-thawed bovine red cells as a 625 
function of the permeation of glycerol and sucrose. J Membr Biol 15 (1974) 137-58. 626 
[34] P. Mazur, Freezing of living cells: mechanisms and implications. Am J Physiol 247 (1984) 627 
C125-42. 628 
[35] P. Mazur, Principles of cryobiology. in: B.J. Fuller, N. Lane, and E.E. Benson, (Eds.), Life 629 
in the frozen state, CRC Press, Boca Raton, FL, 2004, pp. 3-65. 630 
[36] G.C. McKay, C. Henderson, E. Goldie, G. Connel, C. Westmoreland, and M.H. Grant, 631 
Cryopreservation of rat hepatocyte monolayers: cell viability and cytochrome P450 632 
content in post-thaw cultures. Toxicol In Vitro 16 (2002) 71-9. 633 
[37] H.T. Meryman, Cryopreservation of living cells: principles and practice. Transfusion 47 634 
(2007) 935-45. 635 
[38] Y. Miyamoto, S. Enosawa, T. Takeuchi, and T. Takezawa, Cryopreservation in situ of cell 636 
monolayers on collagen vitrigel membrane culture substrata: ready-to-use preparation of 637 
primary hepatocytes and ES cells. Cell Transplant 18 (2009) 619-26. 638 
32 
 
[39] K. Muldrew, and L.E. McGann, The osmotic rupture hypothesis of intracellular freezing 639 
injury. Biophys J 66 (1994) 532-41. 640 
[40] T. Nei, Mechanism of freezing injury to erythrocytes: effect of initial cell concentration on 641 
the post-thaw hemolysis. Cryobiology 18 (1981) 229-37. 642 
[41] J. O'Brien, I. Wilson, T. Orton, and F. Pognan, Investigation of the Alamar Blue (resazurin) 643 
fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267 644 
(2000) 5421-6. 645 
[42] S. Ohtake, and Y.J. Wang, Trehalose: current use and future applications. J Pharm Sci 100 646 
(2011) 2020-53. 647 
[43] A.E. Oliver, K. Jamil, J.H. Crowe, and F. Tablin, Loading human mesenchymal stem cells 648 
with trehalose by fluid phase endocytosis. Cell Preserv Technol 2 (2004) 35-49. 649 
[44] C. Pribenszky, G. Vajta, M. Molnar, Y. Du, L. Lin, L. Bolund, and J. Yovich, Stress for 650 
stress tolerance? A fundamentally new approach in mammalian embryology. Biol Reprod 651 
83 (2010) 690-7. 652 
[45] A.S. Rudolph, and J.H. Crowe, Membrane stabilization during freezing: the role of two 653 
natural cryoprotectants, trehalose and proline. Cryobiology 22 (1985) 367-77. 654 
[46] R.W. Salt, Intracellular freezing in insects. Nature 193 (1962) 1207–1208. 655 
[47] G. Seth, Freezing mammalian cells for production of biopharmaceuticals. Methods 56 656 
(2012) 424-31. 657 
[48] B.J. Sinclair, and D. Renault, Intracellular ice formation in insects: unresolved after 50 658 
years? Comp Biochem Physiol A Mol Integr Physiol 155 (2010) 14-8. 659 
[49] J.H. Son, K.H. Kim, Y.K. Nam, J.K. Park, and S.K. Kim, Optimization of cryoprotectants 660 
for cryopreservation of rat hepatocyte. Biotechnol Lett 26 (2004) 829-33. 661 
33 
 
[50] D.J. Stevenson, C. Morgan, E. Goldie, G. Connel, and M.H. Grant, Cryopreservation of 662 
viable hepatocyte monolayers in cryoprotectant media with high serum content: 663 
metabolism of testosterone and kaempherol post-cryopreservation. Cryobiology 49 664 
(2004) 97-113. 665 
[51] K.B. Storey, and J.M. Storey, Natural freeze tolerance in ectothermic vertebrates. Annu Rev 666 
Physiol 54 (1992) 619-37. 667 
[52] C. Terry, A. Dhawan, R.R. Mitry, and R.D. Hughes, Cryopreservation of isolated human 668 
hepatocytes for transplantation: State of the art. Cryobiology 53 (2006) 149-59. 669 
[53] S.N. Timasheff, The control of protein stability and association by weak interactions with 670 
water: how do solvents affect these processes? Annu Rev Biophys Biomol Struct 22 671 
(1993) 67-97. 672 
[54] P. Watts, and M.H. Grant, Cryopreservation of rat hepatocyte monolayer cultures. Hum Exp 673 
Toxicol 15 (1996) 30-37. 674 
[55] D. Wharton, and D. Ferns, Survival of intracellular freezing by the Antarctic nematode 675 
Panagrolaimus davidi. J Exp Biol 198 (1995) 1381-7. 676 
[56] J. Wolfe, and G. Bryant, Freezing, drying, and/or vitrification of membrane- solute-water 677 
systems. Cryobiology 39 (1999) 103-29. 678 
[57] C.F. Wu, H.C. Tsung, W.J. Zhang, Y. Wang, J.H. Lu, Z.Y. Tang, Y.P. Kuang, W. Jin, L. 679 
Cui, W. Liu, and Y.L. Cao, Improved cryopreservation of human embryonic stem cells 680 
with trehalose. Reprod Biomed Online 11 (2005) 733-9. 681 
[58] G. Xie, and S.N. Timasheff, The thermodynamic mechanism of protein stabilization by 682 
trehalose. Biophys Chem 64 (1997) 25-43. 683 
34 
 
[59] P.H. Yancey, M.E. Clark, S.C. Hand, R.D. Bowlus, and G.N. Somero, Living with water 684 
stress: evolution of osmolyte systems. Science 217 (1982) 1214-22. 685 
 686 
  687 
35 
 
Fig. 1  688 
 689 [trehalose], mM
0 50 100 150
P
e
rc
e
n
ta
g
e
 o
f 
re
c
o
v
e
re
d
 c
e
lls
 
0
25
50
75
100
125
150 0 50 100 150
n
 (
n
u
m
b
e
r 
o
f 
c
e
lls
 *
1
0
6
)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
*
*
*
* *
A
B
36 
 
 690 
Fig. 2 691 
 692 
 693 
  694 
[trehalose], mM
0 50 100 150P
e
rc
e
n
ta
g
e
 o
f 
c
e
lls
 r
e
c
o
v
e
re
d
 a
ft
e
r 
fr
e
e
z
in
g
  
0
2
4
6
8
10
12
14
16
*
*
*
37 
 
Fig. 3 695 
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Fig. 5  701 
 702 
40 
 
Fig. 6 703 
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Fig. 7 706 
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